Showing results (91-100 of 110) with videos related to
Sort By:
Pageof 11
Neurology|September 1, 1987
Carrier assessment for mothers and sisters of isolated Duchenne dystrophy cases: the importance of serum enzyme determinationsC L Hyser, R A Doherty, R C Griggs, et al.Muscle & Nerve|January 1, 1987
Clinical investigation in Duchenne dystrophy. VI. Double-blind controlled trial of nifedipineR T Moxley, M H Brooke, G M Fenichel, et al.Neurology|February 1, 1989
Randomized controlled trial of testosterone in myotonic dystrophyR C Griggs, S Pandya, J M Florence, et al.Muscle & Nerve|September 1, 1984
Clinical investigation in Duchenne muscular dystrophy: IV. Double-blind controlled trial of leucineJ R Mendell, R C Griggs, R T Moxley, et al.Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|September 18, 2003
Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunctionH Mitsumoto, M Davidson, D Moore, et al.Neurology|April 1, 1989
Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapyM H Brooke, G M Fenichel, R C Griggs, et al.Archives of Neurology|June 1, 1991
A comparison of daily and alternate-day prednisone therapy in the treatment of Duchenne muscular dystrophyG M Fenichel, J R Mendell, R T Moxley, et al.The New England Journal of Medicine|June 15, 1989
Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophyJ R Mendell, R T Moxley, R C Griggs, et al.Muscle & Nerve|January 1, 1985
Clinical investigation in Duchenne dystrophy: V. Use of creatine kinase and pyruvate kinase in carrier detectionR C Griggs, J R Mendell, M H Brooke, et al.Annals of Neurology|October 1, 1987
Genetic heterogeneity in Duchenne dystrophyC L Hyser, M Province, R C Griggs, et al.Pageof 11